Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children

American Journal of Clinical Nutrition

Volumn 94, Issue 3, 2011, Pages 749-758

  Le, Hau D ^a   De Meijer, Vincent E ^a   Robinson, Elizabeth M ^a   Zurakowski, David ^a   Potemkin, Alexis K ^a   Arsenault, Danielle A ^a   Fallon, Erica M ^a   Malkan, Alpin ^a   Bistrian, Bruce R ^b   Gura, Kathleen M ^c   Puder, Mark ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BILIRUBIN GLUCURONIDE; CHOLESTEROL; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; FISH OIL LIPID EMULSION; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; INTRALIPID; LINOLEIC ACID; LINOLENIC ACID; LIPID; LIPID EMULSION; LOW DENSITY LIPOPROTEIN; MONOUNSATURATED FATTY ACID; OLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; STEARIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD NUTRITION; CHOLESTASIS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DISEASE ASSOCIATION; DYSLIPIDEMIA; FATTY ACID ANALYSIS; FEMALE; HUMAN; INFANT; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PARENTERAL NUTRITION; TRIACYLGLYCEROL BLOOD LEVEL;

BILIRUBIN; CHOLESTASIS; DIETARY FATS; FAT EMULSIONS, INTRAVENOUS; FEMALE; FISH OILS; HUMANS; INFANT; INFANT, NEWBORN; LIPIDS; MALE; PARENTERAL NUTRITION; SHORT BOWEL SYNDROME; SOYBEAN OIL;

GLYCINE MAX;

EID: 80051963692     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.110.008557     Document Type: Article

References (42)

1. Wretlind A. Development of fat emulsions. JPEN J Parenter Enteral Nutr 1981;5:230-5.
2. Andorsky D.J., Lund D.P., Lillehei C.W., Jaksic T., Dicanzio J., Richardson D.S., Collier S.B., Lo C., Duggan C. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr 2001;139:27-33. (Pubitemid 32613983)
3. Llop J., Sabin P., Garau M., Burgos R., Perez M., Masso J., Cardona D., Sanchez Segura J.M., Garriga R., Redondo S., et al. The importance of clinical factors in parenteral nutrition-associated hypertriglyceridemia. Clin Nutr 2003;22:577-83. (Pubitemid 37455726)
4. Trujillo E.B., Young L.S., Chertow G.M., Randall S., Clemons T., Jacobs D.O., Robinson M.K. Metabolic and monetary costs of avoidable parenteral nutrition use. JPEN J Parenter Enteral Nutr 1999;23:109-13. (Pubitemid 29115429)
5. Tashiro T., Mashima Y., Yamamori H., Okui K. Alteration of lipoprotein profile during total parenteral nutrition with intralipid 10%. JPEN J Parenter Enteral Nutr 1986;10:622-6.
6. De Meijer V.E., Gura K.M., Le H.D., Meisel J.A., Puder M. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: The Boston experience. JPEN J Parenter Enteral Nutr 2009;33:541-7.
7. De Meijer V.E., Gura K.M., Meisel J.A., Le H.D., Puder M. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease. Arch Surg 2010;145:547-51.
8. De Meijer V.E., Gura K.M., Puder M. Parenteral nutrition in the critically ill patient. N Engl J Med 2010;362:81-82, author reply 3-4.
9. Chen M.F., Lee Y.T., Hsu H.C., Yeh P.C., Liau C.S., Huang P.C. Effects of dietary supplementation with fish oil on prostanoid metabolism during acute coronary occlusion with or without reperfusion in diet-induced hypercholesterolemic rabbits. Int J Cardiol 1992;36:297-304.
10. Minihane A.M., Khan S., Leigh-Firbank E.C., Talmud P., Wright J.W., Murphy M.C., Griffin B.A., Williams C.M. ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler Thromb Vasc Biol 2000;20:1990-7.
11. Griffin M.D., Sanders T.A., Davies I.G., Morgan L.M., Millward D.J., Lewis F., Slaughter S., Cooper J.A., Miller G.J., Griffin B.A. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: The OPTILIP Study. Am J Clin Nutr 2006;84:1290-8.
12. Gura K.M., Lee S., Valim C., Zhou J., Kim S., Modi B.P., Arsenault D.A., Strijbosch R.A., Lopes S., Duggan C., et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition- associated liver disease. Pediatrics 2008;121:e678-e86.
13. Puder M., Valim C., Meisel J.A., Le H.D., De Meijer V.E., Robinson E.M., Zhou J., Duggan C., Gura K.M. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009;250:395-402.
14. Skulas-Ray A.C., Kris-Etherton P.M., Harris W.S., Vanden Heuvel J.P., Wagner P.R., West S.G. Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr 2011;93:243-52.
15. Gura K.M., Parsons S.K., Bechard L.J., Henderson T., Dorsey M., Phipatanakul W., Duggan C., Puder M., Lenders C. Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr 2005;24:839-47. (Pubitemid 41403641)
16. Gura K.M., Duggan C.P., Collier S.B., Jennings R.W., Folkman J., Bistrian B.R., Puder M. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: Implications for future management. Pediatrics 2006;118:e197-201. (Pubitemid 46071136)
17. Zeger S.L., Liang K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30.
18. Harrell F. Regression model strategies. New York, NY: Springer, 2001.
19. Holman R.T., Smythe L., Johnson S. Effect of sex and age on fatty acid composition of human serum lipids. Am J Clin Nutr 1979;32:2390-9.
20. Lee S.I., Valim C., Johnston P., Le H.D., Meisel J., Arsenault D.A., Gura K.M., Puder M. Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease. Pediatr Res 2009;66:698-703.
21. Lee S., Gura K.M., Kim S., Arsenault D.A., Bistrian B.R., Puder M. Current clinical applications of omega-6 and omega-3 fatty acids. Nutr Clin Pract 2006;21:323-41.
22. Maki K.C., Lawless A.L., Kelley K.M., Dicklin M.R., Kaden V.N., Orcutt A.L., Rains T.M., Marshall J.W. Effects of prescription omega-3-acid ethyl esters on fasting lipid profile in subjects with primary hypercholesterolemia. J Cardiovasc Pharmacol 2011;57:489-94.
23. Davidson M.H. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol 2006;98(4A):27i-33i.
24. Tai C.C., Ding S.T. N-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: Mechanisms and implications for obesity prevention. J Nutr Biochem 2010;21:357-63.
25. Weldon S.M., Mullen A.C., Loscher C.E., Hurley L.A., Roche H.M. Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. J Nutr Biochem 2007;18:250-8.
26. Clarke G., Fitzgerald P., Hennessy A.A., Cassidy E.M., Quigley E.M., Ross P., Stanton C., Cryan J.F., Dinan T.G. Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndrome. J Lipid Res 2010;51:1186-192.
27. Strijbosch R.A., Lee S., Arsenault D.A., Andersson C., Gura K.M., Bistrian B.R., Puder M. Fish oil prevents essential fatty acid deficiency and enhances growth: Clinical and biochemical implications. Metabolism 2008;57:698-707. (Pubitemid 351608232)
28. Kaaks R., Riboli E., Sinha R. Biochemical markers of dietary intake. IARC Sci Publ 1997; 142:103-26.
29. Riboli E., Ronnholm H., Saracci R. Biological markers of diet. Cancer Surv 1987;6:685-718.
30. Gronn M., Christensen E., Hagve T.A., Christophersen B.O. Effects of dietary purified eicosapentaenoic acid (20: 5 (n-3)) and docosahexaenoic acid (22: 5 (n-3)) and docosahexaenoic acid (226(n-3)) on fatty acid desaturation and oxidation in isolated rat liver cells. Biochim Biophys Acta 1992;1125:35-43.
31. Hrelia S., Lopez Jimenez J.A., Bordoni A., Nvarro S.Z., Horrobin D.F., Rossi C.A., Biagi P.L. Essential fatty acid metabolism in cultured rat cardiomyocytes in response to either N-6 or N-3 fatty acid supplementation. Biochem Biophys Res Commun 1995;216:11-9.
32. Kromhout D., Bosschieter E.B., De Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312:1205-9.
33. Siscovick D.S., Raghunathan T.E., King I., Weinmann S., Wicklund K.G., Albright J., Bovbjerg V., Arbogast P., Smith H., Kushi L.H., et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995;274:1363-7.
34. Mozaffarian D., Kumanyika S.K., Lemaitre R.N., Olson J.L., Burke G.L., Siscovick D.S. Cereal, fruit, and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals. JAMA 2003;289:1659-66.
35. Morgado N., Rigotti A., Valenzuela A. Comparative effect of fish oil feeding and other dietary fatty acids on plasma lipoproteins, biliary lipids, and hepatic expression of proteins involved in reverse cholesterol transport in the rat. Ann Nutr Metab 2005;49:397-406. (Pubitemid 41778666)
36. Peltier S., Louchami K., Zhang Y., Portois L., Hacquebard M., Malaisse W.J., Carpentier Y.A. Alteration of lipid fatty acid profile and cationic fluxes in ventricular cardiomyocytes from omega3-depleted rats. Int J Mol Med 2009;24:343-52.
37. Simons L.A., Hickie J.B., Balasubramaniam S. On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia. Atherosclerosis 1985;54:75-88. (Pubitemid 15174345)
38. Botham K.M., Bravo E. The role of lipoprotein cholesterol in biliary steroid secretion. Studies with in vivo experimental models. Prog Lipid Res 1995;34:71-97.
39. Pedersen M.H., Molgaard C., Hellgren L.I., Lauritzen L. Effects of fish oil supplementation on markers of the metabolic syndrome. J Pediatr 2010;157:395-400.
40. Fujioka S., Hamazaki K., Itomura M., Huan M., Nishizawa H., Sawazaki S., Kitajima I., Hamazaki T. The effects of eicosapentaenoic acid-fortified food on inflammatory markers in healthy subjects - a randomized, placebo-controlled, double-blind study. J Nutr Sci Vitaminol (Tokyo) 2006;52:261-5.
41. Garg M.L., Blake R.J., Clayton E., Munro I.A., Macdonald-Wicks L., Singh H., Moughan P.J. Consumption of an n-3 polyunsaturated fatty acid-enriched dip modulates plasma lipid profile in subjects with diabetes type II. Eur J Clin Nutr 2007;61:1312-7.
42. de Meijer VE, Le HD, Meisel JA, Gura KM, Puder M. Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients. J Pediatr Gastroenterol Nutr 2010;50:212-8.